Measurement of secondary mucositis to oncohematologic treatment by means of different scale;Valoración de la mucositis secundaria a tratamiento oncohematológico mediante distintas escalas. Revisión

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 10, Issue 5, 2005, Pages 412-421

  López Castaño, Fuensanta ^a   Oñate Sánchez, Ricardo E ^a,b   Roldán Chicano, Rocío ^a   Cabrerizo Merino, Ma Carmen ^a  

^a U Doc P Especiales   (Spain)

^b Unidad Docente Patientes Especiales   (Spain)

Author keywords

Chemotherapy; Mucositis; Oncohematology; Review; Transplant of bone marrow; Valuation; X ray

Indexed keywords

ANTINEOPLASTIC AGENT;

BONE MARROW TRANSPLANTATION; BURNING SENSATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; ERYTHEMA; HEMATOLOGIC MALIGNANCY; HUMAN; MOUTH MUCOSA; MUCOSA INFLAMMATION; QUALITY OF LIFE; REVIEW;

ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; DEGLUTITION DISORDERS; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA; MOUTH MUCOSA; MUCOSITIS; RADIOTHERAPY; SEVERITY OF ILLNESS INDEX; STOMATITIS;

EID: 28044468650     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Puyal M, Jiménez C, Chimenos E, López J, Juliá, A. Protocolo de estudio y tratamiento de la Mucositis bucal en los pacientes con hemopatías malignas. Med. Oral 2003;8:10-8
2. Kostler WJ, Hejna M, Wenzel C, Zielinski CC. Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and Treatment. CA Cancer J Clin 2001;51:290-315
3. Porock D. Factors influencing the severity of radiation skin and oral mucosal reactions: development of a conceptual framework. Eur J Cancer Care (Engl) 2002;1:33-43.
4. Dodd MJ, Dibble S, Miaskowski C, Paul S, Cho M, MacPhail L, et al.: A comparison of the affective state and quality of life of chemotherapy patients who do and do not develop chemotherapy-induced oral mucositis. J Pain Sym Manag 2001;21:498-505.
5. McGuire DB. Mucosal tissue injury in cancer therapy. More than muscositis and mouthwash. Cancer Pract 2002;10:179-91.
6. Awidi A, Homsi U, Kakail RI, Mubarak A, Hassan A, Kelta M, et al. Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer. Eur J Cancer 2001;37:2010-4.
7. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998;34:39-43.
8. Gabriel DA, Shea T, Olajida O, Serody JS, Comeau T The effect of oral mucositis on morbidity and mortality in bone marrow transplant. Semin Oncol 2003;30(6 Suppl 18):76-83.
9. Pico JL, Ávila-Garavito A, Naccache P. Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting. Oncologist 1998;3:446-51.
10. Caribé-Gomes F, Chimenos-Küstner E, López López J, Finestres-Zubeldia F, Guix-Melcior B. Manejo odontológico de las complicaciones de la radioterapia y quimioterapia en el cáncer oral. Med Oral 2003;8:178-87.
11. McGuire DB, Altomonte V, Peterson DE, Wingard JR, Jones RJ, Grochow LB. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum 1993;20:1493-502.
12. Wojtaszek CA. Management of chemotherapy induced stomatitis. Clin J Oncol Nurs 2000;4:263-9.
13. Schubert MM. Measurement of oral tissue damage and mucositis pain. En: Chapman CR, Foley KH, eds. Current and Emerging Issues on Cancer Pain: Research and Practice. New York: Raven Press; 1993. p. 247-65.
14. Stokman MA, Spijkervet FK, Wymenga AN, Burlage FR, Timens W, Roodenburg JL, et al. Quantification of oral mucositis due to radiotherapy by determining viability and maturation of epithelial cells. J Oral Pathol Med 2002;31:153-7.
15. Plevova P. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review. Oral Oncol 1999;35:453-70.
16. Lindquist SF, Mickey AJ, Drane JB. Effect of oral hygiene on stomatitis in patients receiving cancer chemotherapy. J Prosthet Dent 1978;40:312-4.
17. Beck S. Impact of a systematic oral care protocol on stomatitis after chemotherapy. Cancer Nurs 1979;2:185-199.
18. Eilers J, Berger AM, Petersen MC. Development, testing, and application of the oral assessment guide. Oncol Nurs Forum 1988;15:325-30.
19. Walsh LJ, Hill G, Seymour G, Roberts A. A scoring system for the quantitative evaluation of oral mucositis during bone marrow transplantation. Spec Care Dentist 1990;10:190-5.
20. Western Consortium for Cancer Nursing Research. Development of a staging system for chemotherapy-induced stomatitis. Cancer Nurs 1991;14:6-12.
21. Cancer Therapy Evaluation Program: Common Toxicity Criteria Version 2.0. DCTD, NCI, NIH, DHHS 1998. Disponible en: http://ctep.cancer.gov/forms/CTCv20_4- 30-992.pdf
22. Epstein JB, Gorsky M, Guglietta A, Le N, Sonis ST. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy. Cancer 2000;89:2258-65.
23. Dazzi C, Cariello A, Giovanis P, Monti M, Vertagen B, Leoni M,et al. Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study. Ann Oncol 2003;14:559-63.
24. Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000 1;47:13-47.
25. Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer 1992 15;69:2469-77.
26. Kolbinson DA, Schubert MM, Flournoy N, Truelove EL. Early oral changes following bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1988;66:130-8.
27. McGuire DB, Peterson DE, Muller S, Owen DC, Slemmons MF, Schubert MM. The 20 item Oral Mucositis Index: reliability and validity in bone marrow and stem cell transplant patients. Cancer Invest. 2002;20:893-903.
28. Spijkervet FKL, van Saene HKF, Panders AK, Vermey A, Mehta DM. Scoring irradiation mucositis in head and neck cancer patients. J Oral Pathol Med 1989;18:167-71.
29. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;30:1341-6.
30. Montero Luis A, Hervás A , Morera R, Ramos A. Toxicidad sobre piel y mucosas: tratamientos de soporte. Oncología 2004;27:402-7
31. Johnson JT. Prevention of radiation-induced mucositis. Curr Oncol Rep 2001;3:56-8.